生命科学资讯

Other news to note for Dec. 23, 2025

Regulatory actions for Dec. 23, 2025

Big pharma taps fast Asia innovation in search of next Keytruda

Novo Nordisk’s weight loss pill approved by FDA

Hepatic adaptation to chronic metabolic stress primes tumorigenesis

Mapping cellular targets of covalent cancer drugs in the entire mammalian body

Despite geopolitical pressures, China biotech deals remain at pace as collective value soars: Evaluate

Hope springs toward Parkinson's phase 3 despite divergent stem cell therapy data

The top 5 stock picks for biotech in 2026: William Blair

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 - Yahoo Finance

Gilead's herpes deal; FDA approvals for Boehringer, Roche

Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D

Math Lab Equipment Market Is Going to Boom |Thermo Fisher Scientific • Agilent Technologies - openPR.com

Labcorp backs Cellens in developing physics test aimed at bladder cancer

Notice of email fulfilment change

Voya Investment Management LLC Cuts Stake in Agilent Technologies, Inc. $A - MarketBeat

Spatial Transcriptomics Market Size, Trends & Growth Report by 2034 - Straits Research

Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsy

Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 - Insider Monkey

Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 - Yahoo Finance